Prevention and treatment of Alzheimer disease and aging: antioxidants.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2007-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/138955707779802552PMID 17305591
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein

  2007cited by this paper
• ApoE-dependent plasticity in Alzheimer’s disease

  2007cited by this paper
• APOE genotype effects on alzheimer’s disease onset and epidemiology

  2007cited by this paper
• Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms

  2006cited by this paper
• Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice.

  2006cited by this paper
• The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target.

  2006cited by this paper
• Therapeutic opportunities in Alzheimer disease: one for all or all for one?

  2005cited by this paper
• Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron*

  2005cited by this paper
• Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.

  2005cited by this paper
• Reflections on the discovery and significance of estrogen receptor beta.

  2005cited by this paper
• Estrogen Bows to a New Master: The Role of Gonadotropins in Alzheimer Pathogenesis

  2005cited by this paper
• Calorie restriction--the SIR2 connection.

  2005cited by this paper
• Resveratrol: preventing properties against vascular alterations and ageing.

  2005cited by this paper
• Nanoparticle and other metal chelation therapeutics in Alzheimer disease.

  2005cited by this paper
• Concepts for the treatment of Alzheimer's disease: molecular mechanisms and clinical application

  2005cited by this paper
• Gender Differences in Alzheimer Disease: The Role of Luteinizing Hormone in Disease Pathogenesis

  2005cited by this paper
• Tau modifiers as therapeutic targets for Alzheimer's disease.

  2005cited by this paper
• Evidence for the role of gonadotropin hormones in the development of Alzheimer disease.

  2005cited by this paper
• Tau phosphorylation in Alzheimer's disease: pathogen or protector?

  2005cited by this paper
• Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.

  2005cited by this paper
• Refining treatment guidelines in Alzheimer's disease.

  2005cited by this paper
• Vitamin C and Vitamin E for Alzheimer's Disease

  2005cited by this paper
• Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection.

  2004cited by this paper
• Glutathione Metabolism during Aging and in Alzheimer Disease

  2004cited by this paper
• Modulation of Hippocampal Plasticity and Cognitive Behavior by Short-term Blueberry Supplementation in Aged Rats

  2004cited by this paper
• Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.

  2004cited by this paper
• A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.

  2004cited by this paper
• Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease

  2004cited by this paper
• Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation.

  2004cited by this paper
• Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia/reoxygenation.

  2004cited by this paper
• Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

  2003cited by this paper
• Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease

  2003cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

  2003cited by this paper
• Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease

  2003cited by this paper
• Epidemiology of neurodegeneration.

  2003cited by this paper
• Dietary intake of antioxidants and risk of Alzheimer disease.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases?

  2002cited by this paper
• Formation of aberrant phosphotau fibrillar polymers in neural cultured cells.

  2002cited by this paper
• Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.

  2002cited by this paper
• Protein aggregates and dementia: is there a common toxicity?

  2002cited by this paper
• The endogenous cannabinoid system controls extinction of aversive memories

  2002cited by this paper
• Inflammation and therapeutic vaccination in CNS diseases

  2002cited by this paper
• High-quality life extension by the enzyme peptide methionine sulfoxide reductase

  2002cited by this paper
• Carbonyl toxicology and Alzheimer's disease.

  2002cited by this paper
• Free radical studies of ellagic acid, a natural phenolic antioxidant.

  2002cited by this paper
• Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.

  2002cited by this paper
• Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease.

  2002cited by this paper
• Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.

  2002cited by this paper
• Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

  2002cited by this paper
• Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.

  2001cited by this paper
• A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

  2001cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death

  2001cited by this paper
• Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction

  2001cited by this paper
• Chemistry and biochemistry of oxidative stress in neurodegenerative disease.

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Inflammation, autotoxicity and Alzheimer disease.

  2001cited by this paper
• Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

  2001cited by this paper
• Overexpression of Heme Oxygenase in Neuronal Cells, the Possible Interaction with Tau*

  2000cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000cited by this paper
• No effect of anti-oxidative therapy on cerebral amyloidosis following ischemia-reperfusion brain injury.

  2000cited by this paper
• Intake of flavonoids and risk of dementia

  2000cited by this paper
• Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

  2000cited by this paper
• Oxidative stress and Alzheimer disease.

  2000cited by this paper
• Vitamin E and Alzheimer disease: the basis for additional clinical trials.

  2000cited by this paper
• Extension of life-span with superoxide dismutase/catalase mimetics.

  2000cited by this paper
• Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.

  2000cited by this paper
• Activation of p38 Kinase Links Tau Phosphorylation, Oxidative Stress, and Cell Cycle‐Related Events in Alzheimer Disease

  2000cited by this paper
• Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.

  2000cited by this paper
• In Alzheimer's Disease, Heme Oxygenase Is Coincident with Alz50, an Epitope of τ Induced by 4‐Hydroxy‐2‐Nonenal Modification

  2000cited by this paper
• Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins.

  2000cited by this paper
• Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias

  2000cited by this paper
• Low education and childhood rural residence

  2000cited by this paper
• The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins.

  2000cited by this paper
• Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins.

  2000cited by this paper
• Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal

  2000cited by this paper
• Postmenopausal estrogen replacement therapy and risk of AD

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• The role of oxidative stress in Alzheimer disease.

  1999cited by this paper
• The influence of smoking on the risk of Alzheimer’s disease

  1999cited by this paper
• [The presenilin mystery. The research winner-by-a knockout?].

  1999cited by this paper
• Pharmacologic Management of Alzheimer Disease Part II: Antioxidants, Antihypertensives, and Ergoloid Derivatives

  1999cited by this paper
• Effects of a soy milk supplement on plasma cholesterol levels and oxidative DNA damage in men – a pilot study

  1999cited by this paper
• An update on the role of free radicals and antioxidant defense in human disease

  1999cited by this paper
• The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties.

  1999cited by this paper
• Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo.

  1999cited by this paper
• Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage.

  1999cited by this paper
• Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

  1999cited by this paper
• Antioxidative resuscitation solution prevents leukocyte adhesion in the liver after hemorrhagic shock.

  1999cited by this paper
• Treatment of Alzheimer's disease.

  1999cited by this paper
• Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging

  1998cited by this paper
• Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study.

  1998cited by this paper
• Attenuation of age-dependent oxidative damage to DNA and protein in brainstem of Tg Cu/Zn SOD mice.

  1998cited by this paper

• Effects of Perilla Seed Pomace Extract on Aging-Induced Cognitive Dysfunction in SAMP8 Mice

  2025cites this paper
• Synthesis of new fluorinated sulfonates and their Schiff bases as anti-Alzheimer drug candidates: An in vitro-in silico study

  2025cites this paper
• Antioxidant Effects and Probiotic Properties of Latilactobacillus sakei MS103 Isolated from Sweet Pickled Garlic

  2023cites this paper
• From kitchen to clinic: Pharmacotherapeutic potential of common spices in Indian cooking in age-related neurological disorders

  2022cites this paper
• Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases

  2020cites this paper
• Novel ketoprofen–antioxidants mutual codrugs as safer nonsteroidal anti‐inflammatory drugs: Synthesis, kinetic and pharmacological evaluation

  2019cites this paper
• Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.

  2019cites this paper
• Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease.

  2019cites this paper
• A Study on the Effect of Vitamin E on Histomorphological and Immunohistochemical Changes Induced By Electromagnetic Field

  2019cites this paper
• Investigating the effects of different natural molecules on the structure and oligomerization propensity of hen egg-white lysozyme.

  2019cites this paper
• N -substituted-piperidines as Novel Anti-alzheimer Agents: Synthesis, antioxidant activity, and molecular docking study

  2018cites this paper
• Design of Multi-target Directed Ligands as a Modern Approach for the Development of Innovative Drug Candidates for Alzheimer’s Disease

  2018cites this paper
• Evaluation of Micronutrients in Fenugreek (Trigonella foenum-graecum L.): A Viable Alternative for Micronutrient Supplementation

  2018cites this paper
• Whey Protein Concentrate and Dexamethasone Protected Rat Cerebellum from Gamma-radiation Injury

  2017cites this paper
• Lithium induced, oxidative stress and related damages in testes and heart in male rats: The protective effects of Malva sylvestris extract.

  2017cites this paper
• Vitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?

  2017cites this paper
• Isolation of polysaccharides from Malva aegyptiaca and evaluation of their antioxidant and antibacterial properties.

  2017cites this paper
• Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2/IRS-1 pathway in diabetic rats.

  2017cites this paper
• Molecular mechanisms and in vitro antioxidant effects of Lactobacillus plantarum MA2.

  2017cites this paper
• Comparative study of the possible protective effect of thymoquinone (black seeds) when compared with vitamin E on acrylamide-induced neurotoxicity in the adult guinea pig cerebellar cortex

  2016cites this paper
• The influence of common free radicals and antioxidants on development of Alzheimer's Disease.

  2016cites this paper
• Calycosin ameliorates diabetes-induced cognitive impairments in rats by reducing oxidative stress via the PI3K/Akt/GSK-3β signaling pathway.

  2016cites this paper
• Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease.

  2016cites this paper
• Kinetics and molecular docking studies of fucosterol and fucoxanthin, BACE1 inhibitors from brown algae Undaria pinnatifida and Ecklonia stolonifera.

  2016cites this paper
• Chemical composition and chelating activity of Ruta chalepensis L. (Rutaceae) essential oil as influenced by phenological stages and plant organs

  2015cites this paper
• Flos Puerariae Extract Ameliorates Cognitive Impairment in Streptozotocin-Induced Diabetic Mice

  2015cites this paper
• Provided for non-commercial research and education use . Not for reproduction , distribution or commercial use

  2014cites this paper
• Vitamin E is essential for Purkinje neuron integrity.

  2014cites this paper
• Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease.

  2014cites this paper
• Multi-Target Directed Drugs: A Modern Approach for Design of New Drugs for the treatment of Alzheimer’s Disease

  2014cites this paper
• Antioxidant capacity and total phenols richness of Cistanche violacea hosting Zygophyllum album

  2013cites this paper
• The Issues of Antioxidant Therapy

  2013cites this paper
• Rational Design of sym-Triazines For Multitarget-directed Modulation of Cholinesterases and Amyloid-beta in Alzheimer’s Disease

  2013cites this paper
• Antioxidant activity of galantamine and some of its derivatives.

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs

  2013cites this paper
• Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

  2012cites this paper
• Effect of Phenological Stage and Geographical Location on Antioxidant Activities of Tunisian Horehound: Marrubium vulgare L. (Lamiaceae)

  2012cites this paper
• Chemical composition of volatile compounds and antioxidant activities of essential oil, aqueous and ethanol extracts of wild Tunisian Ruta chalepensis L. (Rutacea)

  2012cites this paper
• BIOACTIVITY AND PHYTOCHEMICAL ANALYSIS OF AMORPHOPHALLUS COMMUTATUS SCHOTT ENGL AN ENDEMIC AROID OF WESTERN GHATS SOUTH INDIA

  2012cites this paper
• Regulation of vitamin E and the tocopherol transfer protein

  2012influential citation
• Gamma radiation effects in the brain of rats: antioxidant and radioprotective properties of Vernonia amygdalina leaf extract

  2011cites this paper
• Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.

  2011cites this paper
• The Role of Phytochemicals in the Treatment and Prevention of Dementia

  2011cites this paper
• Alzheimer’s Disease and Type 2 Diabetes: Different Pathologies and Same Features

  2011cites this paper
• Frontiers in Alzheimer’s disease therapeutics

  2011cites this paper
• WITHDRAWN: Antioxidant and metal chelating potential of the solvent fractions of Gelidiella acerosa, the red algae inhabiting South Indian coastal area

  2010cites this paper
• Oxidative Stress in Diabetes and Alzheimer's Disease

  2009cites this paper
• Translational medicine perspective in development of disease modifying therapies for Alzheimer's disease: biomarkers to buy down the risk

  2009cites this paper
• Mitochondrial Drugs for Alzheimer Disease

  2009cites this paper
• Scutellaria flavonoid supplementation reverses ageing-related cognitive impairment and neuronal changes in aged rats

  2009cites this paper
• RNA oxidation in Alzheimer disease and related neurodegenerative disorders

  2009cites this paper
• Resveratrol: Its Biologic Targets and Functional Activity

  2009cites this paper
• Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen

  2009cites this paper
• Alzheimer's disease: from pathology to therapeutic approaches.

  2009cites this paper
• Effects of mood stabilizers on DNA damage in an animal model of mania.

  2008cites this paper
• Sublethal RNA Oxidation as a Mechanism for Neurodegenerative Disease

  2008cites this paper
• Vitamin E increases S100B‐mediated microglial activation in an S100B‐overexpressing mouse model of pathological aging

  2008cites this paper
• Crosstalk Between Calcium and Redox Signaling: From Molecular Mechanisms to Health Implications

  2008cites this paper
• Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection.

  2008cites this paper
• RNA Oxidation in Neurodegenerative Diseases: Sublethal Damage as a Mechanism for Chronic Degeneration

  2008cites this paper
• Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates.

  2008cites this paper
• Effect of Chronic N-Acetyl Cysteine Administration on Oxidative Status in the Presence and Absence of Induced Oxidative Stress in Rat Striatum

  2008cites this paper
• Neuroprotective effects of SB‐415286 on hydrogen peroxide‐induced cell death in B65 rat neuroblastoma cells and neurons

  2008influential citation
• Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture.

  2008cites this paper
• Multi-target-directed ligands to combat neurodegenerative diseases.

  2008cites this paper
• Coenzyme Q10 Attenuates β-Amyloid Pathology in the Aged Transgenic Mice with Alzheimer Presenilin 1 Mutation

  2008cites this paper
• The role of oxidative stress and cholesterol in animal models of Alzheimer's disease

  2008cites this paper
• Hydrogen peroxide attenuates insulin-like growth factor-1 neuroprotective effect, prevented by minocycline.

  2007cites this paper
• Oxidative RNA damage and neurodegeneration.

  2007cites this paper
• Aging modifies brain region-specific vulnerability to experimental oxidative stress induced by low dose hydrogen peroxide

  2007cites this paper
• Pathway and mechanism of oxidative stress in Alzheimer's disease

  2007cites this paper
• Aspectos do envelhecimento cerebral e função cognitiva em modelo experimental animal e estudo de mecanismos de neurodegeneração em cultura celular

  2007cites this paper